The aim of this work is to facilitate the fight against COVID-19 pandemic using a comparative
study of seven drug molecules, in order to select the most efficient drug molecules. This …

Azithromycin is an antibiotic proposed as a treatment for the coronavirus disease 2019
(COVID-19) due to its immunomodulatory activity. The aim of this study is to develop dry …

Niclosamide, a potent anthelmintic agent, has emerged as a candidate against COVID‐19 in
recent studies. Its formulation has been investigated extensively to address challenges …

More than two years have passed since the viral outbreak that led to the novel infectious
respiratory disease COVID-19, caused by the SARS-CoV-2 coronavirus. Since then, the …

Niclosamide, an FDA-approved oral anthelmintic drug, has broad biological activity
including anticancer, antibacterial, and antiviral properties. Niclosamide has also been …

Autophagy is an auto-digestive process targeting cytoplasmic cargo for lysosomal
degradation. It is crucial for maintaining cellular homeostasis, and dysregulation of …

SARS-CoV-2 is highly transmissible and pathogenic, with nearly 6.5 million infected people
dying worldwide. A severe acute respiratory syndrome is one of the primary COVID-19 …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the cause of
coronavirus disease-2019 (COVID-19) pandemic is undergoing continuous evolution …

Remote clinical trials present the new approach of revolutionizing traditional clinical trials in
order to decrease costs, accelerate the processes and improve the experience for …

Covalent target modification has re-emerged in recent years as a promising modality for
therapeutic development and mechanistic biochemical analysis. Although slightly colored by …